Junfeng Yan

469 total citations
29 papers, 352 citations indexed

About

Junfeng Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Junfeng Yan has authored 29 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Junfeng Yan's work include Prostate Cancer Treatment and Research (5 papers), Sexual function and dysfunction studies (4 papers) and Cancer Mechanisms and Therapy (4 papers). Junfeng Yan is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Sexual function and dysfunction studies (4 papers) and Cancer Mechanisms and Therapy (4 papers). Junfeng Yan collaborates with scholars based in China, United States and Pakistan. Junfeng Yan's co-authors include Qiang Tong, Huiying Fu, Shahid Ullah Khan, Chen Yang, Rongsheng Tong, Lulu Cai, Pengcheng Jiao, Lin He, Qiyang Shou and Feifei An and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Colloid and Interface Science.

In The Last Decade

Junfeng Yan

27 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfeng Yan China 11 162 58 57 38 35 29 352
Yanhong Lv China 10 119 0.7× 38 0.7× 72 1.3× 54 1.4× 38 1.1× 21 405
Yuxiang Wan China 10 141 0.9× 30 0.5× 28 0.5× 31 0.8× 41 1.2× 47 335
Fangfang Xu China 11 183 1.1× 58 1.0× 34 0.6× 69 1.8× 45 1.3× 56 507
AGM Mostofa Bangladesh 11 172 1.1× 59 1.0× 34 0.6× 87 2.3× 31 0.9× 20 489
Hassan Akrami Iran 14 267 1.6× 120 2.1× 32 0.6× 62 1.6× 55 1.6× 53 536
Cuiliu Liu China 4 186 1.1× 60 1.0× 44 0.8× 58 1.5× 13 0.4× 5 402
Yao Sun China 12 220 1.4× 81 1.4× 63 1.1× 72 1.9× 19 0.5× 29 393
Xinxin Liang China 11 123 0.8× 43 0.7× 62 1.1× 17 0.4× 23 0.7× 49 353
Ruyi Li China 15 295 1.8× 121 2.1× 60 1.1× 49 1.3× 26 0.7× 37 559
Zezhi Huang China 13 176 1.1× 49 0.8× 47 0.8× 46 1.2× 24 0.7× 15 358

Countries citing papers authored by Junfeng Yan

Since Specialization
Citations

This map shows the geographic impact of Junfeng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Yan more than expected).

Fields of papers citing papers by Junfeng Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Yan. The network helps show where Junfeng Yan may publish in the future.

Co-authorship network of co-authors of Junfeng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Yan. A scholar is included among the top collaborators of Junfeng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Yan. Junfeng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yue, Fangfang Chen, Tian Li, et al.. (2025). Clinical implications of DNA ploidy, stroma, and nucleotyping in predicting peritoneal metastasis risk for gastric cancer. BMC Cancer. 25(1). 144–144.
2.
4.
He, Liang, et al.. (2024). Prevalence and associated risk factors of prostate cancer among a large Chinese population. Scientific Reports. 14(1). 26338–26338. 6 indexed citations
5.
Zou, Beiji, et al.. (2024). A novel approach for intelligent diagnosis and grading of diabetic retinopathy. Computers in Biology and Medicine. 172. 108246–108246. 27 indexed citations
6.
Wang, Xing, et al.. (2023). Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer. BMC Urology. 23(1). 148–148. 5 indexed citations
7.
Yan, Junfeng, et al.. (2023). Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response. Frontiers in Oncology. 13. 1192192–1192192. 3 indexed citations
8.
Khan, Shahid Ullah, et al.. (2023). Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis. Biomedicine & Pharmacotherapy. 164. 114986–114986. 52 indexed citations
9.
Yan, Junfeng, et al.. (2022). [Salidroside regulates the phenotypic transformation of corpus cavernosum smooth muscle cells of rats through the PDGFR/STAT3 signaling pathway].. PubMed. 28(2). 107–113. 1 indexed citations
12.
13.
Yu, Yang, et al.. (2022). Alpha-Lipoic Acid Promotes Intestinal Epithelial Injury Repair by Regulating MAPK Signaling Pathways. Mediators of Inflammation. 2022. 1–7. 3 indexed citations
14.
Yan, Junfeng, et al.. (2021). Rare case of brucellosis misdiagnosed as prostate carcinoma with lumbar vertebra metastasis: A case report. World Journal of Clinical Cases. 9(21). 6009–6016. 1 indexed citations
15.
Liu, Xinxia, Yuan Bian, Min Chen, et al.. (2020). Discussion on the application of intestinal microecological regulators in Corona Virus Disease 2019. 22. 1 indexed citations
16.
Duan, Xingmei, Junfeng Yan, Lan Bai, et al.. (2018). Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy. International Journal of Nanomedicine. Volume 13. 1443–1456. 16 indexed citations
17.
Zhao, Fan, et al.. (2017). The Protective Effect of Salidroside on Hypoxia‐Induced Corpus Cavernosum Smooth Muscle Cell Phenotypic Transformation. Evidence-based Complementary and Alternative Medicine. 2017(1). 3530281–3530281. 15 indexed citations
18.
Liu, Xia, Qiyang Shou, Junfeng Yan, et al.. (2016). Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway. Journal of Ethnopharmacology. 193. 538–545. 40 indexed citations
19.
Yan, Junfeng, et al.. (2016). [Effect of salidroside on the expression of connexin43 in the corpus cavernosum smooth muscle cells of hypoxic rats].. PubMed. 22(8). 725–729. 1 indexed citations
20.
Yan, Junfeng, et al.. (2014). Poly(vinylamine) microgel–dextran composite hydrogels: Characterisation; properties and pH-triggered degradation. Journal of Colloid and Interface Science. 449. 21–30. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026